:format(url)/cloudfront-us-east-1.images.arcpublishing.com/lescoopsdelinformation/6EMKJVECS5DDBDHWA56Y3BNEKM.jpeg)
10 May 2022 –
Michelle L. Tremblay and Martin J. Placer, Physicians Emeritus, Purdue University
17 h Domaine du Haut-Carré in Talence
Purdue University awards the title of Doctor Honoris Causa to Michelle L. Canadian Academy of Sciences) and Martin J. Placer (Professor of Medicine at Rutgers University, Director of the Center for Advanced Biotechnology and Medicine and holder of the Henry Rutgers Chair in the Human Microbiome). The ceremony will take place on Tuesday 10 May 2022 at the Domaine du Haut-Carré in Talence.
Michelle L. Tremblay / Martin J. Blaser
a party
The ceremony, entirely in English, is held at the Agora of the Haut-Carré Estate in Talence. The evening will end with a cocktail open to all.
Michael Tremblay
Tremblay, born 1957, is a professor in the departments of biochemistry, microbiology, immunology, and oncology at McGill University. He is one of the world’s top specialists in the role of protein tyrosine phosphatases (PTPs) in particular in cancer, diabetes and obesity. After receiving his PhD from McMaster University, he continued his post-doctoral training at the National Institutes of Health (NIH) in Bethesda, Maryland, in the field of embryonic stem cells. There are the foundations of the first animal model of a human disease resulting from the use of stem cells (Gaucher’s disease).
In 1992, he became an assistant professor in McGill University’s Department of Biochemistry and cloned the genes of several protein tyrosine phosphatase (PTPs) implicated in many human diseases. Since his appointment to McGill University in 1992, Professor Michael L. In 2007, he was awarded the honor of “Discovery of the Year” by the magazine Quebec Science For his work on breast cancer.
Director of the Goodman Center for Cancer Research at McGill University since July 2000, Michel Tremblay is the founder of two biotechnology companies based on his research experience.
He is currently a member of the Executive Board of the Fonds de la recherche en santé du Québec (FRSQ) and President of James McGill. He was accepted as a member of the Royal Canadian Academy of Sciences in 2007.
After taking a year off in 2012 as a visiting scientist at the Institute for Immunology Research (IFReC) at Osaka University, he returned full time to his lab to continue his research on PTPs and found the McGill Regenerative Medicine Network. He was awarded the title of Chevalier de l’Ordre du Québec in 2015 for his exceptional contribution to scientific research, and in 2017 he was awarded the prestigious McLaughlin Medal by the Royal Society of Canada.
The holder of more than fifteen patents, and the author of more than 200 publications in the field of PTPs, Michel Tremblay is an internationally recognized expert in this research field.
Martin J. Placer
Born in 1948 and graduated from New York University School of Medicine in 1973, Martin J. Advanced Biotechnology and Medicine. Director of the Department of Medicine at New York University for 7 years, and notably served as Director of the Human Microbiome Program (NYU School of Medicine).
Professor Placer, a physician and microbiologist, studies the relationships we have with persistent colonizing bacteria. His work spans more than 30 years and mainly focuses on the types of Campylobacter and Helicobacter pylori, which are model systems for understanding the interactions of residential bacteria with their hosts. Over the past 20 years, he has been actively studying the relationship between the human microbiome and health and important diseases such as asthma, obesity, diabetes and cancer.
In 2019, he founded Rutgers University Microbiome Program (RUMP), a university project that aims to advance the science of the microbiome and study its impact on health, agriculture, the environment, and human culture. He is currently the Chair of the Presidential Advisory Board for Antibiotic-Resistant Bacteria (PACCARB) in the United States.
In 2011, Martin Placer was elected a member of National Academy of Medicine, in recognition of his professional achievements and commitment to the service of medicine and health, prior to his election to the American Academy of Arts and Sciences in 2013.
Martin Placer’s scientific career has also been honored with the following awards: the National Academy of Medicine Prize, the Oswald Avery Prize, the Alexander Fleming Prize, and the Robert Koch Prize. He is one of the 100 most influential people in the world in 2015 according to Time magazine.
A holder of 28 US patents, author of 690 original articles, Martin J. Blazer’s scientific output is exceptional. Significantly written Missing Microbes, a book for the general public, now translated into 20 languages. Thanks to this book, Martin Placer shows a great ability to promote, regularly intervenes in other programs and conferences for the general public.
Honour because I am
In the oldest university tradition, the title of Doctor Honoris Causa was formalized in the era of the Third Republic by a decree of June 20, 1918. This honorary title is conferred on dignitaries of foreign nationality, due to outstanding services rendered to the arts, arts, sciences and technology, as well as France or the institution granting Title.
“Music guru. Incurable web practitioner. Thinker. Lifelong zombie junkie. Tv buff. Typical organizer. Evil beer scholar.”
More Stories
Plants grow mostly in the afternoon
Why should we not confuse academic freedom with the autonomy of science?
A revolutionary proposal from a team of NASA researchers exploring physics